Glaxosmithkline | GSK - Los Gastos Financieros De La Deuda

Precio De Mercado
54.44
Cambio Diario
-4.68 -7.92%
Mensual
-8.13%
Anual
45.44%
Q2 Expectativa
53.52




Los Gastos Financieros De La Deuda Cambio Fecha
AbbVie USD 740M 40M 2025-06
Amgen USD 653M 32M 2025-12
AstraZeneca USD 484M 181M 2025-12
Aurora Cannabis CAD 2.11M 116K 2025-12
Bausch Health Companies USD 412M 53M 2025-09
Bristol-Myers Squibb USD 432M 48M 2025-12
Canopy Growth CAD 7.34M 1.46M 2025-12
Corcept Therapeutics USD 823.61M 21.88M 2025-09
Drreddys Laboratories INR 944M 127M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
GlaxoSmithKline GBP 188M 21M 2025-12
Glaxosmithkline GBP 177.95M 6.05M 2025-09
J&J USD 43M 25M 2026-03
Merck USD 412M 85M 2025-12
Novartis USD 304M 23M 2025-12
Pacira USD 3.89M 387K 2025-12
Perrigo USD 10.08B 10.04B 2025-09
Pfizer USD 711M 59M 2025-12
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 178M 203M 2026-03
Supernus Pharmaceuticals USD 910K 278K 2023-06
Takeda JPY 123.63B 40.49B 2025-12
Teva Pharmaceutical Industries USD 220M 17M 2025-12
Zoetis USD 57M 1000K 2025-12